HLA-B27-associated uveitis

Ophthalmology Clinics of North America

Volumn 15, Issue 3, 2002, Pages 297-307

  Smith, Justine R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CORTICOSTEROID; CYTOKINE; HLA B27 ANTIGEN; INFLIXIMAB; PREDNISOLONE ACETATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANKYLOSING SPONDYLITIS; BACTERIAL INFECTION; CATARACT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; EYE DISEASE; GLAUCOMA; GRAM NEGATIVE INFECTION; HLA TYPING; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHACOEMULSIFICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTIVE ARTHRITIS; RETINA MACULA CYSTOID EDEMA; REVIEW; SIDE EFFECT; SPONDYLOARTHROPATHY; UVEITIS;

ACUTE DISEASE; HLA-B27 ANTIGEN; HUMANS; UVEITIS, ANTERIOR;

EID: 0036710602     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(02)00027-5     Document Type: Review

References (78)

1. Ball EJ, Khan MA. HLA-B27 polymorphism. Joint Bone Spine 2001;68:378-82.
2. Khan MA. Update: The twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000;12:235-8.
3. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and HLA-B27. Lancet 1973;2:994-6.
4. Inman RD, Johnston MEA, Hodge M, Falk J, Helewa A. Postdysenteric reactive arthritis: A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum 1988;31:1377-83.
5. Mielants H, Veys EM, Goemaere S, et al. A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology. J Rheumatol 1993;20:1353-8.
6. Banares AA, Jover JA, Fernandez-Gutierrez B, et al. Bowel inflammation in anterior uveitis and spondyloarthropathy. J Rheumatol 1995;22:1112-7.
7. Dougados M, Vam der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy: A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995;38:618-27.
8. Dougados M, Berenbaum F, Maetzel A, Amor B. Prevention of acute anterior uveitis associated with spondyloarthropathy induced by salazosulfapyridine. Rev Rhum Ed Fr 1993;60:81-3.
9. Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Banares A. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 2000;14:340-3.
10. Feltkamp TEW. Are gram negative bacteria involved in HLA-B27 associated uveitis. Br J Ophthalmol 1995;79:718.
11. Blankenberg-Sprenkels SHD, Fielder M, Feltkamp TEW, et al. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 1998;25:743-7.
12. Granfors K, Jalkanen S, Von Essen R, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990;335:685-8.
13. Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta-2 microglobulin: An animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112.
14. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64.
15. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980;286:611-3.
16. Baggia S, Lyons JL, Barkhuizen A, et al. A novel model of bacterially-induced acute anterior uveitis in rats and the lack of effect from HLA-B27 expression. J Invest Med 1997;45:295-301.
17. Dick AD, Siepmann K, Dees C, et al. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis. Invest Ophthalmol Vis Sci 1999;40:2258-67.
18. Smith JR, Hart PH, Parish CR, et al. Experimental melanin-induced uveitis in the Fischer 344 rat is inhibited by anti-CD4 monoclonal antibody, but not mannose-6-phosphate. Clin Exp Immunol 1999;115:64-71.
19. Feltkamp TEW, Khan MA, Lopez de Castro JA. The pathogenic role of HLA-B27. Immunol Today 1996;17:5-8.
20. Ringrose JH. HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Ann Rheum Dis 1999;58:598-610.
21. Colbert RA. HLA-B27 misfolding: A solution to the spondyloarthropathy conundrum? Mol Med Today 2000;6:224-30.
22. Mear JP, Schreiber KL, Munz C, et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathy. J Immunol 1999;163:6665-70.
23. Colbert RA. HLA-B27 misfolding and spondyloarthropathies: Not so groovy after all? J Rheumatol 2000;27:1107-9.
24. Urvater JA, Hickman H, Dzuris JL, et al. Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2. J Immunol 2001;166:3334-44.
25. 2-Microglobulin: A model of human spondyloarthropathies. J Exp Med 1995;182:1153-8.
26. Hermann E, Mayet WJ, Thomssen H, et al. HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia induced Reiter's disease. J Rheumatol 1992;19:1243-6.
27. Kuon W, Holzhutter H-G, Appel H, et al. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases. J Immunol 2001;167:4738-46.
28. Alvarez I, Lopez de Castro JA. HLA-B27 and immunogenetics of spondyloarthropathies. Curr Opin Rheumatol 2000;12:248-53.
29. Peh CA, Burrows SR, Barnden M, et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998;8:531-42.
30. 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999;162:5045-8.
31. Khare SD, Bull MJ, Hanson J, et al. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: A direct role for B27 heavy chains and not B27-derived peptides. J Immunol 1998;160:101-6.
32. Allen RL, Raine T, Haude A, et al. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 2001;167:5543-7.
33. + T lymphocytes. J Immunol 2001;167:2619-24.
34. Martin TM, Rosenbaum JT. Identifying genes that cause disease: HLA-B27, the paradigm, the promise, the perplexity. Br J Ophthalmol 1998;82:1354-5.
35. Edwards JCW, Bowness P, Archer JR. Jekyll and Hyde: The transformation of HLA-B27. Immunol Today 2000;21:256-60.
36. Feltkamp TEW. Non-HLA-B27 genetic factors in HLA-B27 associated diseases. Clin Rheumatol 1996;15:40-3.
37. Taurog JD, Maika SD, Nimman S, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999;169:209-33.
38. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 2001;13:265-72.
39. Goto K, Ota M, Maksymowych WP, et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am J Ophthalmol 1998;126:436-41.
40. Martin TM, Doyle TM, Smith JR, et al. Acute anterior uveitis in families. Invest Ophthalmol Vis Sci 2001;42:S708.
41. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996;114:593-9.
42. McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol 1996;121:35-46.
43. Wakefield D, Montanaro A, McCluskey P. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 1991;36:223-32.
44. Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol 1989;16:792-6.
45. Rothova A, Van Veenendaal WG, Linssen A. Clinical features of acute anterior uveitis. Am J Ophthalmol 1987;103:137-45.
46. Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol 1995;120:351-61.
47. Tay-Keamey ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 1996;121:47-56.
48. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 1998;105:1646-51.
49. Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am 1992;18:143-51.
50. Banares A, Hernandez-Garcia C, Fernandez-Gutierrez B, Jover JA. Eye involvement in the spondyloarthropathies. Rheum Dis Clin North Am 1998;24:771-84.
51. Dodds EM, Lowder CY, Meisler DM. Posterior segment inflammation in HLA B27+ acute anterior uveitis: Clinical characteristics. Ocul Immunol Inflamm 1999;7:85-92.
52. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis: Incidence and prevalence in a small urban community. Arch Ophthalmol 1962;68:502-14.
53. Linssen A, Rothova A, Valkenburg HA, et al. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991;32:2568-78.
54. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995;7:263-9.
55. Lau CS, Burgos-Vargas R, Louthrenoo W, et al. Features of spondyloarthritis around the world. Rheum Dis Clin North Am 1998;24:753-70.
56. Huhtinen M, Karma A. HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol 2000;84:413-6.
57. Bosch-Driessen EH, Lardy NM, Rothova A. Antinuclear antibody and HLA-B27 positive uveitis: Combination of two diseases? Br J Ophthalmol 1997;81:771-3.
58. Konno Y, Numago J, Tsuchiya N, et al. HLA-B27 subtypes and HLA class II alleles in Japanese patients with anterior uveitis. Invest Ophthalmol Vis Sci 1999;40:1838-44.
59. D'Alessandro LP, Forster DJ, Rao NA. Anterior uveitis and hypopyon. Am J Ophthalmol 1991;112:317-21.
60. Rosenbaum JT, Tammaro J, Robertson JE. Uveitis precipitated by nonpenetrating ocular trauma. Am J Ophthalmol 1991;112:392-5.
61. Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997;115:61-4.
62. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 2000;59:67-70.
63. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology 1994;101:1267-74.
64. Linssen A. B27+ disease versus B27-disease. Scand J Rheumatol Suppl 1990;87:111-9.
65. Whitcup SM, Ferris FL. New corticosteroids for the treatment of ocular inflammation. Am J Ophthalmol 1999;127:597-9.
66. Sand BB, Krogh E. Topical indomethacin, a prostaglandin inhibitor, in acute anterior uveitis: A controlled clinical trial of non-steroid versus steroid anti-inflammatory treatment. Acta Ophthalmol 1991;69:145-8.
67. Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E. New treatment options in spondyloarthropathies: Increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol 2001;13:245-9.
68. El-Shabrawi Y, Graz JH. Anti-TNFa therapy with infliximab in the treatment of HLA-B27 associated acute anterior uveitis: A one year follow up. Arthritis Rheum 2001;44:S123.
69. Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001;45:252-7.
70. Wakefield D, McCluskey P, Verma M, et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 1999;42:1894-7.
71. Krishna R, Meisler DM, Lowder CY, et al. Long-term follow-up of extracapsular cataract extraction and posterior chamber intraocular lens implantation in patients with uveitis. Ophthalmology 1998;105:1765-9.
72. Okhravi N, Lightman SL, Towler HM. Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology 1999;106:710-22.
73. Estafanous MFG, Lowder CY, Meisler DM, Ranjana C. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol 2000;131:620-5.
74. Stavrou P, Murray PI. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 1999;128:434-9.
75. Towler HMA, McCluskey P, Shaer B, Lightman S. Long-term follow-up of trabeculectomy with intraoperative 5-Fluorouracil for uveitis-related glaucoma. Ophthalmology 2000;107:1822-8.
76. Molteno ACB, Sayawat N, Herbison P. Otago glaucoma surgery outcome study: Long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology 2001;108:605-13.
77. Prasad S, Kamath GG, Phillips RP. Phacoemulsification in a patient with marked cervical kyphosis. J Cataract Refract Surg 2000;26:1258-60.
78. Rosenbaum JT, Wernick R. Selection and interpretation of laboratory tests for patients with uveitis. Int Ophthalmol Clin 1990;30:238-43.